Cargando…
Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on “The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts”
Autores principales: | Mercorelli, Beatrice, Luganini, Anna, Palù, Giorgio, Gribaudo, Giorgio, Loregian, Arianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409840/ https://www.ncbi.nlm.nih.gov/pubmed/30699923 http://dx.doi.org/10.3390/v11020117 |
Ejemplares similares
-
The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts
por: Nukui, Masatoshi, et al.
Publicado: (2018) -
Drug Repurposing for Viral Infectious Diseases: How Far Are We?
por: Mercorelli, Beatrice, et al.
Publicado: (2018) -
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives
por: Mercorelli, Beatrice, et al.
Publicado: (2011) -
Divide et impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication
por: Ghassabian, Hanieh, et al.
Publicado: (2021) -
Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism
por: Loregian, Arianna, et al.
Publicado: (2007)